<DOC>
	<DOCNO>NCT02502656</DOCNO>
	<brief_summary>This study evaluate concordance RAS mutation detection result obtain circulate tumor DNA obtain `` standard '' method ( test tumor tissue ) .</brief_summary>
	<brief_title>RAS Mutation Testing Circulating Blood Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Pathologically confirm metachronous synchronous metastatic colorectal cancer No prior chemotherapy exception adjuvant chemotherapy complete â‰¥ 6 month prior enrollment Signed write informed consent obtain prior study specific screening procedure Patients willing provide blood sample Translational Research No tumor block available Previous malignancy last 5 year Medical , sociological , psychological legal condition would permit patient sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>RAS mutation</keyword>
	<keyword>DNA</keyword>
	<keyword>Colorectal Cancer</keyword>
</DOC>